Joseph P Hagan Insider Trading $OREX Orexigen Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph P Hagan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph P Hagan. Joseph P Hagan is Chief Business Officer in Orexigen Therapeutics, Inc. ($OREX) and Sr. VP, Corporate Development in Orexigen Therapeutics, Inc. ($OREX) and Chief Operating Officer in Regulus Therapeutics Inc. ($RGLS) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN).
Joseph P Hagan in Orexigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph P Hagan: Chief Business Officer, Sr. VP, Corporate Development
Holdings: 13,026 shares
Current Value: $59,659
Latest Transaction: Feb 05 2015
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joseph P Hagan in Orexigen Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, OREX, RGLS, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2015 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 5.34 | 202,650 | 1,082,151 | 202,650 | |
| Sep 15 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Buy | P | 4.69 | 5,000 | 23,450 | 13,026 | 8 K to 13 K (+62.30 %) |
| Feb 11 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 6.30 | 225,000 | 1,417,500 | 225,000 | |
| Feb 11 2014 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Grant | A | 5.34 | 3,980 | 21,253 | 3,980 | 0 to 4 K |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 12,000 | 19,920 | 764,000 | |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.80 | 12,000 | 93,600 | 0 | 12 K to 0 (-100.00 %) |
| Aug 02 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 12,000 | 19,920 | 12,000 | 0 to 12 K |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 10,000 | 16,600 | 776,000 | |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.40 | 10,000 | 74,000 | 0 | 10 K to 0 (-100.00 %) |
| Jul 29 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 10,000 | 16,600 | 10,000 | 0 to 10 K |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 28,000 | 46,480 | 786,000 | |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 7.00 | 28,000 | 196,000 | 0 | 28 K to 0 (-100.00 %) |
| May 30 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 28,000 | 46,480 | 28,000 | 0 to 28 K |
| Feb 19 2013 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 5.69 | 310,000 | 1,763,900 | 310,000 | |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 30,000 | 49,800 | 814,000 | |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.90 | 10,000 | 69,000 | 0 | 10 K to 0 (-100.00 %) |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.70 | 20,000 | 134,000 | 10,000 | 30 K to 10 K (-66.67 %) |
| Jul 13 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 30,000 | 49,800 | 30,000 | 0 to 30 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 12,000 | 19,920 | 844,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 26,000 | 43,160 | 856,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | M | 1.66 | 70,000 | 116,200 | 882,000 | |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 6.30 | 12,000 | 75,600 | 0 | 12 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 12,000 | 19,920 | 12,000 | 0 to 12 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.90 | 26,000 | 153,400 | 0 | 26 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 26,000 | 43,160 | 26,000 | 0 to 26 K |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.50 | 30,000 | 165,000 | 0 | 30 K to 0 (-100.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 5.25 | 20,000 | 105,000 | 30,000 | 50 K to 30 K (-40.00 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Sell | S | 4.90 | 20,000 | 98,000 | 50,000 | 70 K to 50 K (-28.57 %) |
| Jun 29 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Buy | M | 1.66 | 70,000 | 116,200 | 70,000 | 0 to 70 K |
| Jan 26 2012 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 2.58 | 350,000 | 903,000 | 350,000 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 1.70 | 450,000 | 765,000 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.94 | 107,000 | 314,580 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.94 | 45,000 | 132,300 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 6.74 | 50,000 | 337,000 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.83 | 175,000 | 495,250 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 2.83 | 125,000 | 353,750 | 0 | |
| Jul 26 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 1.66 | 952,000 | 1,580,320 | 952,000 | |
| Jun 14 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Chief Business Offi ... | Option Exercise | A | 1.69 | 450,000 | 760,500 | 450,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.94 | 107,000 | 314,580 | 107,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 9.31 | 107,000 | 996,170 | 0 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.94 | 45,000 | 132,300 | 45,000 | |
| Mar 04 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | D | 5.89 | 45,000 | 265,050 | 0 | |
| Jan 20 2011 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 9.31 | 107,000 | 996,170 | 107,000 | |
| Sep 22 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 5.89 | 45,000 | 265,050 | 45,000 | |
| Sep 02 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 2.83 | 125,000 | 353,750 | 125,000 | |
| Jan 26 2010 | OREX | Orexigen Therapeut ... | Hagan Joseph P | Sr. VP, Corporate D ... | Option Exercise | A | 6.74 | 50,000 | 337,000 | 50,000 |
Page: 1